Jodek Sodu Na131i Polatom

Sodium Iodide, the active ingredient in Jodek Sodu Na131i Polatom, is a radioactive iodine presented as a N/A/oral preparation for oral use. It is used for thyroid imaging, treatment of hyperthyroidism, and therapy of thyroid cancer in appropriate patients.

GNH USA supplies Jodek Sodu Na131i Polatom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, sourced from the European Union market.

Sodium Iodide (Na131I) is employed in thyroid‑related diagnostic and therapeutic pathways.

Thyroid imaging: enables high‑resolution scintigraphy for accurate assessment of thyroid anatomy and function. Hyperthyroidism treatment: delivers targeted radiation to reduce overactive thyroid tissue. Thyroid cancer therapy: provides ablative radiation to eliminate residual or metastatic thyroid carcinoma cells.

Sodium Iodide (Na131I) may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea or vomiting - Metallic taste in the mouth - Salivary gland swelling or discomfort - Mild headache or fatigue

Serious or Rare Side Effects: - Severe hypothyroidism requiring hormone replacement - Bone marrow suppression leading to cytopenias - Allergic reactions such as rash, angioedema, or anaphylaxis

Sodium Iodide (Na131I) requires careful patient assessment and monitoring.

Pregnancy: avoid unless benefits outweigh risks. Breastfeeding: discontinue use and advise cessation of nursing. Thyroid function monitoring: perform baseline and periodic serum TSH/T4 tests. Radiation safety: limit exposure to staff and family members, follow shielding protocols. Renal impairment: assess renal function before administration. Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Sodium Iodide (Na131I) can interact with several medications that affect thyroid function or iodine handling.

Major Interactions (Avoid): - Antithyroid drugs (e.g., propylthiouracil, methimazole) - Lithium therapy - Amiodarone - Concurrent radioactive iodine procedures

Moderate Interactions (Monitor Closely): - Beta‑blockers (may mask hyperthyroid symptoms) - ACE inhibitors (potential impact on renal iodine clearance) - Calcium or iron supplements (may reduce oral absorption)